+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluzone"

FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
From
From
From
Disease Analysis: Seasonal Influenza Vaccines - Product Thumbnail Image

Disease Analysis: Seasonal Influenza Vaccines

  • Report
  • June 2021
  • 54 Pages
  • Global
Seasonal Influenza Vaccines - Product Thumbnail Image

Seasonal Influenza Vaccines

  • Report
  • October 2020
  • 51 Pages
  • Global
Fluzone High-Dose - Product Thumbnail Image

Fluzone High-Dose

  • Report
  • January 2019
  • 12 Pages
  • Global
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Fluzone is a brand of influenza vaccine manufactured by Sanofi Pasteur, a global biopharmaceutical company. The vaccine is approved for use in individuals aged 6 months and older, and is available in both injectable and intranasal forms. It is designed to protect against the four most common strains of influenza virus. The vaccine is typically administered annually, usually in the fall, to provide protection against the flu season. Fluzone is one of many influenza vaccines available on the market. Other brands include Afluria, Fluarix, Flucelvax, and Flublok. These vaccines are typically administered by healthcare providers in a doctor's office or clinic. In addition, some pharmacies and retail stores offer flu shots. The market for influenza vaccines is highly competitive, with many companies offering similar products. Some of the major players in the market include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more